Schisandra Chinensis Polysaccharide Ameliorates Renal Dysfunction by Inhibiting Inflammatory Reactions and Oxidative Stress in Diabetic Rats
Journal of Medicinal Food · 2025
DOI: 10.1089/jmf.2024.k.0285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Food, 2025. Verfasst von Chunmei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Beihua University, Jilin, China. Hauptthemen laut MEDLINE: Schisandra, Oxidative Stress, Polysaccharides, Kidney. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Schisandra chinensis (S. chinensis) polysaccharide (SCP) is an active ingredient from S. chinensis used mainly for the treatment of diabetes, owing to its antioxidant, hypoglycemic, and lipidemic-modulating activities. A rat type II diabetes mellitus model was established by giving rats a high-fat diet and streptozotocin (STZ) to investigate the protective effect of SCP against renal injury in diabetic rats. It was found in this study that fasting blood glucose, serum lipids, serum creatinine, and blood urea nitrogen levels were decreased, the insulin sensitivity was increased, and pathological injuries of the kidney were alleviated in SCP-treated groups, indicating that SCP should have a protective effect against renal injury in diabetic rats. SCP treatment reduced serum C-reactive protein and inhibited the expression of nuclear factors-κB and related inflammatory factors in the renal tissue of diabetic rats. SCP treatment also regulated the expression of Nuclear factor (erythroid-derived 2) like-2, heme oxygenase-1, and kelch-like ECH-associated protein-1, reduced serum malondialdehyde content, and increased superoxide dismutase activity. Furthermore, SCP down-regulated the expression of fibronectin, α-SMA, transforming growth factor β1, and p-Smad3, up-regulated Smad7 expression, and mitigated the collagen fiber deposition in the renal interstitium in diabetic rats. It can be concluded that the mechanism of SCP in alleviating renal injury may be related to inhibiting inflammation, increasing antioxidant stress capacity, and improving renal fibrosis in diabetic rats.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, Beihua University, Jilin, China.
- Department of Hand Surgery, Affiliated Hospital, Beihua University, Jilin, China.
- Department of Molecular Biology Test Technique, College of Medical Technology, Beihua University, Jilin, China.
- Department of Endocrinology, Affiliated Hospital, Beihua University, Jilin, China.
Zitieren
APA
Wang, C., Li, T., Lin, C., Qiu, X., Zhuang, W., Li, H., Feng, X., Du, X., & Sun, J. (2025). Schisandra Chinensis Polysaccharide Ameliorates Renal Dysfunction by Inhibiting Inflammatory Reactions and Oxidative Stress in Diabetic Rats. Journal of Medicinal Food. https://doi.org/10.1089/jmf.2024.k.0285
Vancouver
Wang C, Li T, Lin C, Qiu X, Zhuang W, Li H, et al. Schisandra Chinensis Polysaccharide Ameliorates Renal Dysfunction by Inhibiting Inflammatory Reactions and Oxidative Stress in Diabetic Rats. Journal of Medicinal Food. 2025. doi:10.1089/jmf.2024.k.0285
BibTeX
@article{Wang2025,
author = {Wang, Chunmei and Li, Ting and Lin, Chengcheng and Qiu, Xudong and Zhuang, Wenyue and Li, He and Feng, Xingming and Du, Xingxu and Sun, Jinghui},
title = {Schisandra Chinensis Polysaccharide Ameliorates Renal Dysfunction by Inhibiting Inflammatory Reactions and Oxidative Stress in Diabetic Rats},
journal = {Journal of Medicinal Food},
year = {2025},
doi = {10.1089/jmf.2024.k.0285}
}
EUVIMED